Developing models for studying infectious diseases like Ebola in non-human primates.
Official title: Task B16: Model Development and Medical Countermeasures (MCMs) for BSL-4 Agents in NHPs
Funded at University of Texas Med Br Galveston · NIH-11197719 · Data updated 2026-11-12
This study is looking at how we can better understand and treat infectious diseases like Ebola by using non-human primates, which could eventually lead to new treatments that help patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Med Br Galveston NIH-funded |
| Lab location | 1 site (Galveston, United States) |
| Project start | June 25, 2024 |
| Project end | June 24, 2027 |
| Funding year | 2024 |
| Award (this year) | $1,610,509 |
| NIH project number | 272201700040I-0-759302400002-1 |
| Project ID | NIH-11197719 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research include individuals at risk of contracting infectious diseases like Ebola or those involved in healthcare and research related to these conditions.
✕Less likely to help
Patients with non-infectious diseases or those not at risk for infectious diseases may not receive any benefit from this research.
What this research studies
This research focuses on creating and improving models using non-human primates to better understand infectious diseases, particularly Ebola. By evaluating potential medical countermeasures, the research aims to identify effective treatments and preventive strategies. Patients may benefit indirectly through advancements in therapies that emerge from this work, as it seeks to enhance our understanding of how these diseases affect living organisms. The approach involves rigorous testing and evaluation of candidate therapeutic agents in a controlled environment.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective treatments and vaccines for severe infectious diseases.
How similar studies have gone: Previous research has shown success in developing models for infectious diseases, indicating that this approach has potential for significant advancements.
Where this research is happening
-
University of Texas Med Br Galveston
Galveston, United States Active
Researchers
- Principal investigator: Beasley, David — University of Texas Med Br Galveston
- Study coordinator: Beasley, David
Related research
Other NIH-funded projects on the same topics.
-
HPV and pregnancy risk: a big study following 1,280 pregnancies
A large pregnancy study at UTMB looks at whether human papillomavirus (HPV) during pregnancy is linked to problems like preterm birth.
-
West African Center for Emerging Infectious Diseases
A national West African collaboration is studying how dangerous viruses spread between animals and people, with the goal of improving prevention and response.
-
West African Center for Emerging Infectious Diseases
A multi-country program in West Africa aims to better understand how emerging infectious diseases spread from animals to people and how to prevent outbreaks that could affect the U.S.
-
West Africa Center for Emerging Infectious Diseases
A patient-facing center in West Africa studies how emerging viruses spread to people and livestock so we can better protect communities and prevent outbreaks.
-
West African Center for Emerging Infectious Diseases
Aiming to understand and prevent emerging viruses in West Africa to protect people in the U.S. and globally.
-
West Africa Center for Emerging Infectious Diseases
A US-funded center in West Africa aims to better understand and prevent outbreaks of deadly viruses by studying how diseases spread between animals, people, and the environment.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.